-- phpMyAdmin SQL Dump
-- version 5.2.1
-- https://www.phpmyadmin.net/
--
-- Host: localhost:8889
-- Generation Time: Jan 08, 2025 at 02:43 PM
-- Server version: 5.7.39
-- PHP Version: 8.2.0

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
START TRANSACTION;
SET time_zone = "+00:00";

--
-- Database: `galliprant_trivia`
--
CREATE DATABASE IF NOT EXISTS `galliprant_trivia` DEFAULT CHARACTER SET utf8 COLLATE utf8_general_ci;
USE `galliprant_trivia`;

-- --------------------------------------------------------

--
-- Table structure for table `gameplays`
--

CREATE TABLE `gameplays` (
  `id` int(11) UNSIGNED NOT NULL,
  `score` int(1) UNSIGNED NOT NULL,
  `datetime` int(10) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

-- --------------------------------------------------------

--
-- Table structure for table `questions`
--

CREATE TABLE `questions` (
  `id` int(11) UNSIGNED NOT NULL,
  `question` text NOT NULL,
  `answer` enum('true','false') NOT NULL,
  `blurb` text NOT NULL,
  `note` text NOT NULL,
  `footnote` text
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `questions`
--

INSERT INTO `questions` (`id`, `question`, `answer`, `blurb`, `note`, `footnote`) VALUES
(1, 'In canine osteoarthritis, the primary source of pain comes from the degradation of articular cartilage, which has a high concentration of nerve endings.', 'false', 'Articular cartilage lacks nerve endings; pain is primarily due to inflammation and changes in surrounding structures.', 'Galliprant targets pain and inflammation at the EP4 receptor, reducing pain at its source without inhibiting COX enzymes.', NULL),
(2, 'In dogs, the progression of osteoarthritis often results in decreased range of motion and joint instability, contributing to further cartilage erosion.', 'true', 'OA leads to joint instability and reduced mobility, worsening cartilage degeneration.', 'Galliprant provides effective intervention by targeting inflammation and pain, helping maintain joint mobility.', NULL),
(3, 'OA isn’t common in dogs.', 'false', 'Over 40% of dogs develop OA by age four.<sup>1</sup>', 'Galliprant offers targeted treatment for early and advanced&nbsp;stages of OA, improving mobility and helping slow&nbsp;disease progression.', '<sup>1</sup>Enomoto M, de Castro N, Hash J, et al. Prevalence of radiographic appendicular osteoarthritis and associated clinical<br>signs in young dogs. Sci Rep. 2024;14(1):282'),
(4, 'Long-term corticosteroids are recommended for managing osteoarthritis in dogs.', 'false', 'Long-term corticosteroids are not recommended for managing osteoarthritis in dogs. Their chronic use poses significant risks, including immunosuppression, gastrointestinal ulcers, and potential cartilage damage.<sup>*</sup>', 'Galliprant is safe for long-term use providing effective relief in symptoms.<sup>1</sup>', '*COAST Development Group\'s International Consensus Guidelines for the Treatment of Canine Osteoarthritis.<br>Frontiers in Veterinary Science, 2023. DOI: https://pubmed.ncbi.nlm.nih.gov/37601753/<br>\n<sup>1</sup>Monitoring is recommended if using long-term.'),
(5, 'NSAID therapy for OA should be administered daily for&nbsp;at least three months for effective management.', 'true', 'Daily NSAID therapy is recommended for months, and many dogs may require lifelong treatment.', 'Galliprant targets the source of canine pain and inflammation while reducing the impact on the kidney and liver health of treated dogs.<sup>*</sup>', '<sup>*</sup>Monitoring is recommended if used long-term'),
(6, 'Galliprant controls pain by inhibiting COX enzymes.', 'false', 'Galliprant targets the EP4 receptor without blocking&nbsp;COX enzymes.', 'Unlike traditional NSAIDs, Galliprant provides effective pain relief&nbsp;by targeting the EP4 receptor, avoiding COX enzyme inhibition. This approach reduces inflammation while reducing the impact on the gastrointestinal system and other organs.', NULL),
(7, 'Galliprant treats both pain and inflammation, while Librela<sup>&reg;</sup> is indicated for the control of OA pain.', 'true', 'Galliprant addresses both pain and inflammation caused by OA by blocking the EP4 receptor, whereas&nbsp;Librela<sup>&reg;</sup> targets only pain.', 'Galliprant provides broad-spectrum treatment, helping to improve mobility and quality of life for dogs with OA.', NULL),
(8, 'Unlike COX-inhibitors, Galliprant does not inhibit the production of prostanoids.<sup>1</sup>', 'true', 'Galliprant targets the EP4 receptor without inhibiting&nbsp;prostanoid production, unlike COX‑inhibitors.<sup>1</sup>', 'Galliprant fights osteoarthritis pain in dogs in a unique way by&nbsp;targeting the underlying joint inflammation, which makes it&nbsp;safe for long-term use.<sup>*</sup>', '<sup>1</sup>Kirkby Shaw K, et al. Vet Med Sci. 2016;2:3-9<br><span class=\"second\"><sup>*</sup>Monitoring is recommended if using long term</span>');

-- --------------------------------------------------------

--
-- Table structure for table `user_answers`
--

CREATE TABLE `user_answers` (
  `id` int(11) UNSIGNED NOT NULL,
  `gameplay_id` int(11) UNSIGNED NOT NULL,
  `question_id` int(11) UNSIGNED NOT NULL,
  `user_choice` enum('true','false') NOT NULL,
  `result` enum('correct','incorrect') NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Indexes for dumped tables
--

--
-- Indexes for table `gameplays`
--
ALTER TABLE `gameplays`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `questions`
--
ALTER TABLE `questions`
  ADD PRIMARY KEY (`id`);

--
-- Indexes for table `user_answers`
--
ALTER TABLE `user_answers`
  ADD PRIMARY KEY (`id`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `gameplays`
--
ALTER TABLE `gameplays`
  MODIFY `id` int(11) UNSIGNED NOT NULL AUTO_INCREMENT;

--
-- AUTO_INCREMENT for table `questions`
--
ALTER TABLE `questions`
  MODIFY `id` int(11) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=9;

--
-- AUTO_INCREMENT for table `user_answers`
--
ALTER TABLE `user_answers`
  MODIFY `id` int(11) UNSIGNED NOT NULL AUTO_INCREMENT;
COMMIT;